Genetic testing has hit the Internet! Now, any consumer with a
computer and access to the Web can find a company—often
with absolutely no connection to healthcare or professional medical
services—offering genetic tests for just about anything.
For the right price, of course.
Whether you’re a laboratory professional, pathologist, scientist,
clinical chemist or lab administrator, you should be concerned
about the threat of unregulated genetic tests offered by Internet
companies to any consumer willing to pay for it. Because these
offerings can, and will, have an impact on your bottom line.
When consumers can bypass physicians and established medical laboratories
to get their own genetic tests—whether for serious illnesses
or something more frivolous, like predicting eye color or a person’s
musical talents—there’s no turning back. In this new,
Internet-dominated world of genetic testing, pathologists and
other clinically trained laboratory professionals like you will
no longer be the first choice for your expertise, advice, and
support.
Get
answers to your own questions and learn what steps you can take
to protect your lab when you join THE DARK REPORT for, “Genetic
Tests On The Internet: Understanding The Dangers—And Opportunities—For
Your Lab!” on Wednesday, June 25, 2008 beginning at 1:00
p.m. EDT (10:00 a.m. Pacific).
THE DARK REPORT AUDIO CONFERENCE DETAILS
DATE:
Wednesday, June 25, 2008
TIME: 1 p.m. EDT; 12 p.m. CDT; 11 a.m. MDT; 10 a.m.
PDT
PLACE: Your telephone or speakerphone
COST: $195 per dial-in site (unlimited attendance
per site) by 6/20/08; $245 thereafter
TO ORDER CD:Click
here or call 1-800-560-6363 toll-free
For
one low price—just $195 (through 6/20/08; $245 thereafter)—you
and your entire team can take part in this fast-paced, insightful
audio conference. Best of all, you’ll be able to connect
personally with our speakers when we open up the phone lines for
live Q&A.
Here’s just some what you’ll learn during this comprehensive
90-minute audio conference:
Why
growing numbers of consumers are seeking out genetic tests online
and are willing to pay $1,000 or more (out of pocket) for them.
How
technological changes now allow companies to offer genetic testing
and molecular diagnostics online directly to consumers.
DNA
Direct’s successful business model as an Internet-based,
scientifically validated source of genetic tests, professional
counseling services, and comprehensive information—and
how this model could work for your company, too.
The
business strategies of companies like 23andMe.com, Navigene.com,
and DecodeGenetics.com that attracted substantial capital investments
from companies like Google.
How
to anticipate the consequences of this trend and its impact
on your lab.
How
to master the strategies that can help your lab compete in this
new online genetic testing world.
Proven methods for developing consumer-friendly approaches to
serving local customers who come to your clinical lab or pathology
group with questions about genetic testing.
Trisha
Brown MS, CGC, is the Vice President of Clinical
Affairs for DNA Direct and is responsible for the day-to-day clinical
operations and development of new clinical products and strategies.
Ms. Brown is an executive with more than 16 years of experience
in the business of medical genetics. Prior to joining DNA Direct,
she was an Associate Vice President at LabCorp and Director of
Strategic Technology Management and Implementation. In this role,
she oversaw the commercialization of new technologies and developed
expertise in operations, project management, strategic planning
and product development. She was also responsible for LabCorp’s
genetic counseling services. Ms. Brown has clinical experience
and has provided genetic counseling for prenatal, craniofacial,
cancer and pediatric patients. She is a board certified genetic
counselor, with an M.S. degree in Human Genetics from Sarah Lawrence
College.
Robert L.
Michel is Editor-in-Chief of THE DARK REPORT,
an intelligence service and publication providing economic and
strategic assessment of the clinical laboratory industry for senior
executives and pathologists. He produces the “Executive
War College on Laboratory and Pathology Management,” which
has an international reputation as a source of innovative and
effective management strategies and business models for pathologists
and laboratory executives. Mr. Michel’s expertise is strategic
analysis, corporate planning and market trend assessment. He was
Director of Strategic Analysis and Special Projects for the regional
laboratory division of Nichols Institute prior to and through
its merger with Corning Clinical Laboratories (now Quest Diagnostics
Incorporated). His corporate experience includes executive positions
with Proctor & Gamble Distributing Company, Financial Corp.
of America and Centex Corporation. In addition, he is a winner
of the Newsletter and Electronic Publisher Association’s
prestigious “Best Investigative Reporting” Award and
is listed in Marquis Who’s Who in Healthcare and Medicine.
Mr. Michel earned a B.A. in Economics from UCLA.
